文献速递神经技术与安全MR

健康大鼠脑内钆长期滞留:钆匹醇、钆布醇与钆双胺的比较

Long-term Gadolinium Retention in the Healthy Rat Brain: Comparison between Gadopiclenol, Gadobutrol, and Gadodiamide.
PubMed 文献 · Radiology · 2022-06-21

在健康Sprague Dawley大鼠中比较钆匹醇、钆布醇与钆双胺注射后1年脑内钆滞留,两种大环类药剂小脑未见T1信号增高且约80%钆在1至12个月间被清除,钆双胺1个月时小脑钆浓度显著更高且12个月仅清除15%并检测到大分子结合钆。

要点

  • 钆匹醇与钆布醇在健康大鼠脑内分布和清除相似,小脑未见T1信号增高。
  • 钆双胺1个月时小脑钆浓度显著高于两种大环类药剂,12个月仅清除15%。
  • 钆双胺组检测到与大分子结合的钆,两种大环类仅见低分子量钆。

核心结论

  • 钆匹醇与钆布醇在健康大鼠脑内的钆分布和清除相似,末次注射后12个月内与钆双胺明显不同。

研究设计与样本

  • 研究于2018年5月至2020年4月进行,9周龄健康Sprague Dawley大鼠接受5次注射(钆匹醇、钆布醇、钆双胺各2.4 mmol钆/kg体重,或生理盐水对照),历时5周,每组6只雌性和6只雄性,末次注射后1、3、5或12个月处死前行MRI,脑组织经ICP-MS测总钆、SEC-ICP-MS表征钆形态、LA-ICP-MS元素成像,同一时间点两两比较用Mann-Whitney检验。

关键影像表现/征象

  • 两种大环类药剂在小脑均未见T1信号高信号。
  • 钆双胺组1个月时小脑钆浓度2.65 nmol/g,显著高于两种大环类药剂(P < .001)。
  • 钆双胺组12个月时小脑钆浓度2.25 nmol/g,仅清除15%,并检测到与大分子结合的钆。
  • 元素成像显示钆沉积模式与铁共定位。

诊断标准与关键数值

  • 1个月时小脑钆浓度:钆布醇0.30 nmol/g,钆匹醇0.37 nmol/g。
  • 12个月时小脑钆浓度:钆布醇0.062 nmol/g,钆匹醇0.078 nmol/g。
  • 两种大环类药剂1个月至12个月间约80%钆被清除。
  • 12个月时两种大环类药剂可溶部分仅检测到低分子量钆。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

Background Safety concerns caused by gadolinium retention call for the development of high-relaxivity gadolinium-based contrast agents (GBCAs) allowing minimal dosing. Purpose To investigate brain gadolinium retention in healthy rats after exposure to gadopiclenol (Elucirem, Guerbet; macrocyclic GBCA) compared with gadobutrol (Gadovist or Gadavist, Bayer; macrocyclic GBCA) and gadodiamide (Omniscan, GE Healthcare; linear GBCA) over 1 year. Materials and Methods In this study conducted between May 2018 and April 2020, 9-week-old healthy Sprague Dawley rats received five injections of either gadopiclenol, gadobutrol, or gadodiamide (2.4 mmol of gadolinium per kilogram of body weight for each), or saline (control animals) over a period of 5 weeks. Rats were randomly assigned to different groups (six female and six male rats per group). MRI examinations were performed before euthanasia at 1, 3, 5, or 12 months after the last injection. Brains were sampled to determine the total gadolinium content via inductively coupled plasma mass spectrometry (ICP-MS), to characterize gadolinium species with size exclusion chromatography (SEC)-ICP-MS, and to perform elemental mapping with laser ablation (LA)-ICP-MS. Mann-Whitney tests were performed on pairwise comparisons of the same time points. Results For both macrocyclic agents, no T1 signal hyperintensities were observed in the cerebellum, and approximately 80% of gadolinium washout was found between 1 month (gadobutrol, 0.30 nmol/g; gadopiclenol, 0.37 nmol/g) and 12 months (gadobutrol, 0.062 nmol/g; gadopiclenol, 0.078 nmol/g). After 12 months, only low-molecular-weight gadolinium species were detected in the soluble fraction. Gadodiamide led to significantly higher gadolinium concentrations after 1 month in the cerebellum (gadodiamide, 2.65 nmol/g; P < .001 vs both macrocyclics) combined with only 15% washout after 12 months (gadodiamide, 2.25 nmol/g) and with gadolinium detected bound to macromolecules. Elemental bioimaging enabled visualization of gadolinium deposition patterns colocalized with iron. Conclusion Gadopiclenol and gadobutrol demonstrated similar in vivo distribution and washout of gadolinium in the healthy rat brain, markedly differing from gadodiamide up to 12 months after the last injection. © RSNA, 2022 Online supplemental material is available for this article.

来源:Radiology,查看原文。版权归原作者所有。

引用

  1. Funke, Factor, Rasschaert, et al. Long-term Gadolinium Retention in the Healthy Rat Brain: Comparison between Gadopiclenol, Gadobutrol, and Gadodiamide. Radiology. 2022. PMID: 35727155. doi:10.1148/radiol.212600

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。